← FDA DRUG APPROVALS

FDA ANDA · ANDA206128

METHOCARBAMOL

Sponsor: EUGIA PHARMA

APPLICATION
ANDA206128
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-27
LATEST ACTION
2016-05-27
ROUTE
INTRAMUSCULAR, INTRAVENOUS, IM-IV
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

METHOCARBAMOLPrescription
METHOCARBAMOL 1GM/10ML (100MG/ML) · SOLUTION · IM-IV

Approval history

2016-05-27UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →